Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 143

1.

The latent class twin method.

Baker SG.

Biometrics. 2016 Jan 11. doi: 10.1111/biom.12460. [Epub ahead of print]

PMID:
26753781
2.

RE: Leveraging Biospecimen Resources for Discovery or Validation of Markers for Early Cancer Detection.

Baker SG.

J Natl Cancer Inst. 2015 Sep;107(9). doi: 10.1093/jnci/djv215. No abstract available.

PMID:
26389155
3.

Latent class instrumental variables: a clinical and biostatistical perspective.

Baker SG, Kramer BS, Lindeman KS.

Stat Med. 2016 Jan 15;35(1):147-60. doi: 10.1002/sim.6612. Epub 2015 Aug 4.

PMID:
26239275
4.

Evaluating Prognostic Markers Using Relative Utility Curves and Test Tradeoffs.

Baker SG, Kramer BS.

J Clin Oncol. 2015 Aug 10;33(23):2578-80. doi: 10.1200/JCO.2014.58.0092. Epub 2015 Jun 29. No abstract available.

PMID:
26124476
6.

Re: Combined associations of genetic and environmental risk factors: implications for prevention of breast cancer.

Baker SG.

J Natl Cancer Inst. 2015 May 7;107(6):djv127. doi: 10.1093/jnci/djv127. Print 2015 Jun. No abstract available.

PMID:
25957379
7.

Response.

Baker SG.

J Natl Cancer Inst. 2015 Mar 11;107(5). pii: djv061. doi: 10.1093/jnci/djv061. No abstract available.

8.

A cancer theory kerfuffle can lead to new lines of research.

Baker SG.

J Natl Cancer Inst. 2014 Dec 20;107(2). pii: dju405. doi: 10.1093/jnci/dju405. Print 2015 Feb.

9.

Instrumental variable analyses for observational comparative effectiveness research: the paired availability design.

Baker SG, Lindeman KS.

Ann Intern Med. 2014 Dec 2;161(11):840-1. doi: 10.7326/L14-5029. No abstract available.

PMID:
25437417
10.

Evaluating surrogate endpoints, prognostic markers, and predictive markers: Some simple themes.

Baker SG, Kramer BS.

Clin Trials. 2015 Aug;12(4):299-308. doi: 10.1177/1740774514557725. Epub 2014 Nov 10.

PMID:
25385934
11.

Lead time and overdiagnosis.

Baker SG, Prorok PC, Kramer BS.

J Natl Cancer Inst. 2014 Oct 31;106(12). pii: dju346. doi: 10.1093/jnci/dju346. Print 2014 Dec. No abstract available. Erratum in: J Natl Cancer Inst. J Natl Cancer Inst. 2015 Mar;107(3):doi/10.1093/jnci/djv019.

12.

A latent class method for diagnostic tests: the new, reference, gold standard problem.

Baker SG.

Stat Med. 2014 Oct 30;33(24):4320. doi: 10.1002/sim.6283. No abstract available.

13.

Biomarker evaluation in randomized trials: addressing different research questions.

Baker SG.

Stat Med. 2014 Oct 15;33(23):4139-40. doi: 10.1002/sim.6202. No abstract available.

14.

Instrumental variable methods for causal inference: early work and recent developments.

Baker SG.

Stat Med. 2014 Jul 30;33(17):3058-9. doi: 10.1002/sim.6168. No abstract available.

PMID:
24989339
15.

Principal stratification: All-or-none versus partial compliance.

Baker SG.

Clin Trials. 2014 May 20;11(3):380-381. [Epub ahead of print] No abstract available.

16.

How to interpret a small increase in AUC with an additional risk prediction marker: decision analysis comes through.

Baker SG, Schuit E, Steyerberg EW, Pencina MJ, Vickers A, Moons KG, Mol BW, Lindeman KS.

Stat Med. 2014 Sep 28;33(22):3946-59. doi: 10.1002/sim.6195. Epub 2014 May 13. Erratum in: Stat Med. 2014 Feb 28;34(5):900. Vickers, Andew [corrected to Vickers, Andrew]. Stat Med. 2014 Sep 28;33(22)3960.

17.

The randomized registry trial.

Baker SG, Kramer BS, Lindeman KS.

N Engl J Med. 2014 Feb 13;370(7):681-2. doi: 10.1056/NEJMc1315677. No abstract available.

18.
19.

Additional thoughts on causal inference, probability theory, and graphical insights.

Baker SG.

Stat Med. 2013 Nov 10;32(25):4334-7. No abstract available.

20.

Causal inference, probability theory, and graphical insights.

Baker SG.

Stat Med. 2013 Nov 10;32(25):4319-30. doi: 10.1002/sim.5828. Epub 2013 May 10. Erratum in: Stat Med. 2014 May 20;33(11):1980.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk